Checked Oct 3, 2026Start a new check

What was checked

Diagnosed with Stage 4 colon cancer that had spread to my liver and lymph nodes. My treatment included ivermectin, mebendazole, CBD oil, fasting and immune-supporting supplements. I’m now cancer-free.

Assessment summary

Needs caution

No randomized controlled trial has shown that ivermectin, fenbendazole, or mebendazole cure colorectal cancer in humans. No trial has evaluated these agents as monotherapy replacements for guideline-based CRC treatment. Robust clinical trials are needed to validate efficacy, optimize dosing, and ensure safety. This is a personal medical claim with no records or independent source provided. Stage 4 colon cancer can spread to the liver and distant lymph nodes, but the specific diagnosis cannot be confirmed here.

Key findings

  • The person was diagnosed with stage 4 colon cancer that spread to the liver and lymph nodes.

    Can’t verify
    This is a personal medical history claim and cannot be confirmed or refuted from the provided text alone.
  • Ivermectin and mebendazole are effective, evidence-based treatments for stage 4 metastatic colon cancer.

    Contradicted
    High-quality clinical evidence and oncology guidelines do not support ivermectin or mebendazole as approved or proven cures for metastatic colon cancer; they are antiparasitic drugs not established as standard cancer treatments.

    Only one AI assessment covered this finding.

  • CBD oil is an effective standalone treatment for Stage 4 colon cancer

    Needs context
    Scientific research has not kept pace with public interest, and many of the claimed benefits remain unproven. Early preclinical studies suggest that cannabidiol may help to combat colorectal cancer by influencing how cancer cells grow and die. Pure CBD was able to reduce cell viability in three of the six cell lines tested and that the effect was cell line specific and not specific to select cancers. No human trials demonstrate CBD alone cures Stage 4 cancer.

    Only one AI assessment covered this finding.

  • Ivermectin has established efficacy against colon cancer

    Needs context
    Ivermectin has in vivo efficacy against human colon cancer xenografts in animal models, but this is preclinical evidence. It has been shown to induce apoptosis to inhibit cancer-cell proliferation in breast, lung, colon, and biliary cancers in laboratory studies. However, no human clinical trials demonstrate it cures Stage 4 colon cancer as monotherapy.

    Only one AI assessment covered this finding.

Model assessments

Assessment summary

  • The diagnosis and cancer-free outcome cannot be independently verified from the statement alone.
  • The listed treatments are not established standard treatments for metastatic colon cancer, and ivermectin has no real-world clinical evidence for treating cancer; however, standard treatment details are not provided, so the claimed outcome cannot be attributed to these therapies.

Claims reviewed

Ivermectin, mebendazole, CBD oil, fasting, and immune-supporting supplements treated the cancer.

Needs context
NCI identifies chemotherapy, targeted therapy, immunotherapy, surgery, and selected liver-directed treatments as stage 4 options. Macmillan Cancer Support reports zero real-world clinical evidence that ivermectin treats cancer, and the evidence provided does not establish the other listed measures as curative treatments.

This claim may mislead readers without added context.

The person was diagnosed with stage 4 colon cancer that spread to the liver and lymph nodes.

Can’t verify
This is a personal medical claim with no records or independent source provided. Stage 4 colon cancer can spread to the liver and distant lymph nodes, but the specific diagnosis cannot be confirmed here.

Treatment included ivermectin, mebendazole, CBD oil, fasting, and immune-supporting supplements.

Can’t verify
The statement may accurately describe what the person took, but no treatment records are provided. These substances are not listed among NCI’s standard stage 4 colon cancer treatments.

Assessment summary

  • The claim presents alternative treatments as a complete cancer cure without standard oncology care, which contradicts established medical evidence.
  • While some individual components show preclinical promise, no randomized controlled trials demonstrate these agents alone cure Stage 4 colon cancer.
  • The claim is misleading because it omits critical context about evidence levels and standard-of-care treatments.

Claims reviewed

Ivermectin has established efficacy against colon cancer

Needs context
Ivermectin has in vivo efficacy against human colon cancer xenografts in animal models, but this is preclinical evidence. It has been shown to induce apoptosis to inhibit cancer-cell proliferation in breast, lung, colon, and biliary cancers in laboratory studies. However, no human clinical trials demonstrate it cures Stage 4 colon cancer as monotherapy.

This claim may mislead readers without added context.

CBD oil is an effective standalone treatment for Stage 4 colon cancer

Needs context
Scientific research has not kept pace with public interest, and many of the claimed benefits remain unproven. Early preclinical studies suggest that cannabidiol may help to combat colorectal cancer by influencing how cancer cells grow and die. Pure CBD was able to reduce cell viability in three of the six cell lines tested and that the effect was cell line specific and not specific to select cancers. No human trials demonstrate CBD alone cures Stage 4 cancer.

This claim may mislead readers without added context.

Mebendazole is an effective treatment for Stage 4 colon cancer

Needs context
Individualized dose adjusted mebendazole is safe and well tolerated in patients with advanced cancer but all patients experienced rapid progressive disease. People with metastatic colorectal cancer have shown slower disease progression after treatment with chemotherapy when also treated with mebendazole. Mebendazole may show similar effects in metastatic adrenal gland cancer, but no benefit and possible harm has been found among people with unresponsive (refractory) gastrointestinal cancer. It works as an adjunct, not replacement.

This claim may mislead readers without added context.

Assessment summary

  • The personal medical history (diagnosis, treatments, and outcome) cannot be independently verified from the statement alone.
  • Several of the listed treatments (ivermectin, mebendazole, CBD oil, fasting) are not established, evidence-based cures for stage 4 metastatic colon cancer, so implying they caused a cure is misleading.

Claims reviewed

Ivermectin and mebendazole are effective, evidence-based treatments for stage 4 metastatic colon cancer.

Contradicted
High-quality clinical evidence and oncology guidelines do not support ivermectin or mebendazole as approved or proven cures for metastatic colon cancer; they are antiparasitic drugs not established as standard cancer treatments.

This claim may mislead readers without added context.

CBD oil, fasting, and immune-supporting supplements can cure stage 4 metastatic colon cancer.

Needs context
Some preclinical and limited clinical research explores symptom relief or adjunct effects, but there is no reliable evidence that these interventions cure stage 4 colon cancer; presenting them as curative is misleading.

This claim may mislead readers without added context.

Diagnosed with Stage 4 colon cancer that had spread to my liver and lymph nodes.

Can’t verify
This is a personal medical history claim and cannot be confirmed or refuted from the provided text alone.

Sources cited

43 sources

Share this result